| Title: |
Glycemic and weight control in people with type 2 diabetes: A real-world observational study in primary care. |
| Authors: |
Orozco-Beltran, D1,2,3,4 (AUTHOR); Mata-Cases, M1,5,6 (AUTHOR); Artola-Menéndez, S1,7 (AUTHOR); Álvarez-Guisasola, F1,8 (AUTHOR); Cebrián-Cuenca, AM1,9 (AUTHOR) anicebrian@gmail.com; Pérez, A6,10,11 (AUTHOR) |
| Source: |
Primary Care Diabetes. Feb2025, Vol. 19 Issue 1, p7-14. 8p. |
| Abstract: |
To analyze glycemic and bodyweight control in people with type 2 diabetes mellitus (T2DM), and prescribing patterns in primary care. We reviewed the electronic medical records of 5009 randomly selected T2DM patients, from 70 health centers in Spain. We analyzed results by age group and presence/absence of obesity. All data were collected in 2022. Regarding treatment, 13.2 % of the sample were on lifestyle therapy only, 76.5 % received metformin, 37.6 % SGLT2 inhibitors, 32.2 % DPP-4 inhibitors, 12.2 % GLP-1 agonists, 18.9 % insulin, 6.5 % sulfonylureas, and 1.3 % glitazones. Glycated Hemoglobin (HbA1c) was below 7 % in 57.7 % of patients, and 62.3 % met their individualized HbA1c targets. Overall, 42 % of the population was obese (45.6 % of women vs 39.1 % of men; p = 0.001). Obesity rates decreased with age in both sexes. We found no association between obesity and poor glycemic control (HbA1c |
| Database: |
Supplemental Index |